Sonendo to Participate at the Gilmartin Group Emerging Growth Company Showcase

2 years ago

LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Sonendo, Inc. (NYSE: SONX), a leading dental technology company and developer of the GentleWave® System, today announced…

Three Amwell® Health System Clients to Lead Hybrid Care Panel at Oracle Health Conference

2 years ago

Leaders from Aultman Health, Banner Health and Children’s National Hospital to share successes with Amwell platforms and Oracle Health integrationBOSTON--(BUSINESS…

Biocure Technology Inc. Enters into Exclusive Letter Agreement to Acquire Atriva Therapeutics GmbH in Reverse Takeover Transaction

2 years ago

Vancouver, British Columbia--(Newsfile Corp. - September 18, 2023) - Biocure Technology Inc. (CSE: CURE) ("CURE" or the "Company") announces that…

FloraWorks Announces Updated Analysis of Landmark Clinical Trial; CBN Shown Effective for Sleep

2 years ago

Radicle Science found TruCBN(TM) to significantly improve sleep outcomes in first-ever placebo-controlled trial of pure CBNPortland, Oregon--(Newsfile Corp. - September…

iTolerance, Inc. Bolsters Global Intellectual Property with Issuance of European Patent for Proprietary Regenerative SA-FasL Microgel Technology, iTOL-100

2 years ago

Company leveraging iTOL-100 to advance a pipeline of programs that have the potential to cure diseases, such as Type 1…

Avinger Initiates Full Commercial Launch of Tigereye ST Image-Guided CTO Crossing Device

2 years ago

REDWOOD CITY, CA / ACCESSWIRE / September 18, 2023 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the…

Oncocyte’s VitaGraftTM Kidney Identifies Transplant Rejection 10 Months Earlier

2 years ago

Interventional study compares VitaGraft to current transplant rejection monitoring protocolsOncocyte's VitaGraft assay detects antibody-mediated transplant rejection 10 months sooner than…

FSD Pharma announces Interim Results from First-in-Human Clinical Trial of Lucid-MS (Lucid-21-302) for Multiple Sclerosis; The Report Shows Compound to be Safe and Well Tolerated

2 years ago

TORONTO, ON / ACCESSWIRE / September 18, 2023 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma" or the "Company"), a biopharmaceutical…

TRIANA Biomedicines to Present at UBS Biotechnology Private Company Virtual Symposium

2 years ago

LEXINGTON, MA / ACCESSWIRE / September 18, 2023 / TRIANA Biomedicines, Inc. (TRIANA), an innovative biopharmaceutical company focused on advancing…

Ainos’ VELDONA Granted Orphan Drug Designation by U.S. FDA for Potential Treatment of Oral Warts in HIV-Seropositive Patients

2 years ago

VELDONA® positioned as a potential treatment option for over 24,000 HIV-seropositive AmericansSAN DIEGO, CA / ACCESSWIRE / September 18, 2023…